Isidakamizwa esinenkanyezi engaphezu kuka-$9 billion i-Qilu ingumkhiqizo wasekhaya wokuqala okubikwe ukuthi ukhiqizwa.

1.Isidakamizwa esinenkanyezi engaphezu kuka-$9 billion i-Qilu ingumkhiqizo wasekhaya wokuqala okubikwe ukuthi ukhiqizwa.I-Qilu pharmaceutical ithole ukwamukelwa kwe-CDE yokufakwa kuhlu kwesisombululo se-Aflibercept intraocular injection esihanjiswe isigaba somuthi omusha 3.3, okuwumkhiqizo wokuqala okubikiwe womuthi ofanayo we-Aflibercept e-China.

2.Ngomhla ziyi-11 kuNhlaba, uhlelo lokufakwa kuhlu lwesixazululo se-levosalbuterol hydrochloride lokuhogela i-athomu oluthunyelwe yi-Hunan Warner Pharmaceutical Co., Ltd. olunesigaba sesi-3 somuthi ojwayelekile lwamukelwe yi-CDE.I-Levosalbuterol ivame ukusetshenziswa i-β2 receptor agonists.Ngokwemininingwane ye-Intranet, ukuthengiswa kwe-terminal l-salbutamol Hydrochloride Aerosol Inhalation Solution ezikhungweni zezokwelapha zomphakathi e-China ngo-2021 kwakucishe kube ngama-yuan ayizigidi ezingama-200, nokunyuka konyaka ngonyaka okungaphezu kuka-3209%.

3.Umjovo we-sodium we-Enoxaparin ungenise ebhizinisini lesihlanu elihloliwe.Ukusondela kokuthengwa okuphakathi kwenze abadlali abasemkhakheni we-heparin bangaphumuli.Ngokwemininingwane ye-Intranet, ukuthengiswa kwe-heparin esibulalayo kanye namalungiselelo e-heparin enesisindo esiphansi samangqamuzana ezikhungweni zezokwelapha zaseShayina kudlule ama-yuan ayizigidi eziyizinkulungwane eziyi-12 ngo-2021, nokukhuphuka konyaka ngo-12.98%.Phakathi kwemikhiqizo eyi-10 ephezulu, umjovo we-sodium we-enoxaparin waqhubeka nokuhola, futhi ukuthengiswa kwemikhiqizo engu-9 kwanda kakhulu.Phakathi kwamabhizinisi amahlanu ahlanganisa amalungiselelo e-Heparin API, amasheya e-Heprui, e-Jianyou kanye ne-Changshan yezemithi ahole imali yebhizinisi le-Heparin ngo-2021, okwenza isimo sezingxenye ezintathu.

4.Umcimbi wokwethulwa kwechweba lokungeniswa kwezidakamizwa lase-Zhongshan kanye neqoqo lokuqala lokugunyazwa kwentela yokungenisa izidakamizwa ububanjelwe echwebeni lase-Zhongshan i-Sinotrans Wharf e-Zhongshan Torch Development Zone, esifundazweni sase-Guangdong.Iqoqo lokuqala le-“cefotaxime sodium” kanye ” ne-Zhupo powder yezingane” engeniswe yi-Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. kanye ne-Hong Kong Baohetang Pharmaceutical Co., Ltd. iqede ngempumelelo imvume yokungena ezweni, yaba iqoqo lokuqala lemithi engenisiwe ukuba ibe kusuliwe ethekwini.

5.Ngomhla zingama-25 kuNhlaba, i-aosaikang iphinde yafaka isicelo sokumakethwa kwemithi emisha ye-dextrolanzoprazole ekilasini 2.2 yomjovo.I-Takeda pharmaceutical inokulungiswa ngomlomo kuphela kwe-dextrolanzolanzole.Ngo-2021, ithengise ama-yen angaphezu kwezigidigidi ezingama-50.7 (cishe amaRandi ayizigidi ezingama-400) emhlabeni jikelele.Okwamanje, akukho kungenisa noma ukugunyazwa kwasekhaya kwemikhiqizo ehlobene yalolu hlobo emakethe yasekhaya.

6.Ngomhla zingama-25 kuNhlaba, i-Zhejiang Puli Pharmaceutical Co., Ltd. yathumela isicelo somtholampilo somuthi omusha wesigaba 2.2 wezinhlayiyana ze-memantine hydrochloride.I-Memantine iwuhlobo oluthengiswa kakhulu lwemithi elwa nokuwohloka komqondo yezidakamizwa zesistimu yezinzwa.Njengamanje, kukhona amaphilisi, amaphilisi kanye nama-ejenti oketshezi lomlomo emakethe, futhi awekho ama-granules avunyelwe ukufakwa kuhlu noma ukungeniswa.I-Puli yibhizinisi lokuqala ukufaka isicelo somtholampilo sama-granules.

7.Ngomhla zingama-27 kuNhlaba, i-Shandong new era Pharmaceutical Co., Ltd. yathumela isicelo sokufakwa kuhlu sezinhlobo ezine zokulingisa amaphilisi e-etoxaban toluenesulfonate.Okwamanje, awukho umuthi ojwayelekile wasekhaya walo mkhiqizo emakethe.I-Hainan Xiansheng Pharmaceutical Co., Ltd., i-Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. kanye ne-Nanjing Hailing Pharmaceutical Co., Ltd. ye-Yangzijiang Pharmaceutical Group ithumele ukuze kukhiqizwe, okusabuyekezwayo nokuvunywa, kanye nengxabano ngejenerikhi yokuqala. izidakamizwa ziya ngokuya ziba nolaka.I-Edoxaban iyi-elective factor Xa inhibitor eyakhiwe yi-Sankyo yokuqala.Yaqala ukugunyazwa i-venous thromboembolism e-Japan ngo-2011, kwase kuvunyelwa inombolo yezinkomba ezintsha.Ngo-2021, ukuthengiswa komhlaba wonke kwafinyelela kuma-yen ayizigidi eziyizinkulungwane ezingama-189.4 (cishe amadola ayizigidi eziyizinkulungwane eziyi-1.5).

I-JinDun Medicalinokubambisana kocwaningo lwesayensi yesikhathi eside kanye nokuxhunyelelwa kwezobuchwepheshe namanyuvesi aseShayina.Ngezinsiza zezokwelapha ezicebile ze-Jiangsu, inobudlelwano besikhathi eside bokuhwebelana ne-India, i-Southeast Asia, iNingizimu Korea, iJapan nezinye izimakethe.Iphinde inikeze izinsizakalo zemakethe nezokuthengisa kuyo yonke inqubo kusukela ku-API yomkhiqizo omaphakathi kuya oqediwe.Sebenzisa izinsiza eziqoqiwe ze-JinDun Chemical kukhemistri ye-fluorine ukuze unikezeizinsiza ezikhethekile zokwenza amakhemikhalikubalingani.Nikeza inqubo emisha kanye nezinsizakalo zocwaningo lokungcola ukuze uqondise amakhasimende.